Intellia therapeutics News
Latest conceptually matching events and reports for Intellia therapeutics.
Health
Intellia Therapeutics' CRISPR Gene-Editing Treatment Shows Strong Results in Pivotal Trial.
April 27, 2026 at 11:16 AM
Intellia Therapeutics has reported successful Phase 3 trial results for its in vivo CRISPR gene-editing treatment targeting hereditary angioedema (HAE), positioning it for potential FDA approval.
Image Credit : statnews.com